AIM ImmunoTech financials at a glance

+ Portfolio

The revenue of AIM ImmunoTech is reported as 0.0002 billion Dollars in the fiscal year 2023. The earnings were -0.63 Dollars per share in 2023, which was 70.27 lower than 2022. And about -0.01653 billion Dollars are reported as free cash flow in the financials of AIM ImmunoTech 2023. No dividends were paid to the shareholders of the AIM ImmunoTech stock NYSEAM:AIM in the financial year 2023.

$0.20M

Revenue

$-0.63

Earnings Per Share

79.21%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

0.20

Earnings Per Share

-0.63

Gross Margin %

79.21

Free Cash Flow

0.00

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2014	2013	2012	2011	2010	2007	2006	2004
Rev.	Revenue	N/A	$0.20M	$0.14M	$0.14M	$0.16M	$0.14M	$0.37M	$0.20M	$0.15M	$0.00M	$0.16M	$0.14M	$1.06M	$0.93M	$1.23M
GM %	Gross Margin %	84.46%	79.21%	100.00%	0.00%	0.00%	0.00%	-,140.87%	0.00%	0.00%	0.00%	0.00%	0.00%	12.18%	-36.66%	-71.85%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-0.43	$-0.63	$-0.37	$-0.36	$-0.49	$-3.51	$-9.89	$-48.53	$-48.68	$-63.36	$-36.96	$-52.80	$-,132.00	$-,163.68	$-,110.88
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	49.9M	48.41M	47.99M	47.82M	27.63M	1.42M	0.41M	0.34M	0.32M	0.26M	0.26M	0.14M	0.13M	0.09M
OCF	Operating Cash Flow	N/A	$-15.80M	$-16.11M	$-13.97M	$-10.40M	$-9.07M	$-10.64M	$0.00M	$-16.83M	$0.00M	$0.00M	$-11.89M	$0.00M	$0.00M	$0.00M
FCF	Free Cash Flow	N/A	$-16.53M	$-16.20M	$-14.01M	$-10.42M	$-9.14M	$-10.69M	$0.00M	$-17.73M	$0.00M	$0.00M	$-12.62M	$0.00M	$0.00M	$0.00M
FCFS	Free Cash Flow Per Share	$-0.38	$-0.45	$-0.34	$-0.31	$-0.34	$-2.59	$-10.72	$-41.29	$-56.93	$-71.52	$-47.30	$-51.03	$-,114.18	$-,129.58	$-88.80

AIM ImmunoTech financials at a glance

Financials

Discover